首页
400-620-6333
小分子和化合物库
选项
-
白蛋白 来源于鸡蛋白IUPAC Name: 3,4-dihydroxy-2-methoxy-4-methyl-3-[2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]cyclohexan-1-oneSMILES: CC(=CCC1C(O1)(C)C2(C(C(=O)CCC2(C)O)OC)O)CInChIKey: UOXVFQCRPDLSFN-UHFFFAOYSA-NInChI: 1S/C16H26O5/c1-10(2)6-7-12-15(4,21-12)16(19)13(20-5)11(17)8-9-14(16,3)18/h6,12-13,18-19H,7-9H2,1-5H3
-
咪鲜安CAS号: 67747-09-5 EC号: 266-994-5分子式: C15H16Cl3N3O2 分子量: 376.67IUPAC Name: N-propyl-N-[2-(2,4,6-trichlorophenoxy)ethyl]imidazole-1-carboxamideSMILES: CCCN(CCOC1=C(C=C(C=C1Cl)Cl)Cl)C(=O)N2C=CN=C2InChIKey: TVLSRXXIMLFWEO-UHFFFAOYSA-NInChI: 1S/C15H16Cl3N3O2/c1-2-4-20(15(22)21-5-3-19-10-21)6-7-23-14-12(17)8-11(16)9-13(14)18/h3,5,8-10H,2,4,6-7H2,1H3
-
Belantamab mafodotin (anti-BCMA)关联靶标: TNFRSF17
- 简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAF)
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-VC-PAB-MMAF
CAS号: 2050232-20-5SMILES: [Belantamab mafodotin] -
Lifastuzumab vedotin (anti-SLC34A2)关联靶标: SLC34A2
- 简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-VC-PAB-MMAE
CAS号: 1401812-88-1 -
Lorvotuzumab mertansine (anti-NCAM1)关联靶标: NCAM1
- 简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (SMCC-DM1)
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: SMCC-DM1
CAS号: 1008106-64-6 -
Lutikizumab (anti-IL1a&IL1b)
- 简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1791411-57-8 -
Labetuzumab govitecan (anti-CEACAM5)关联靶标: CEACAM5
- 简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (CL2A-SN-38)
- 种属反应性: 人(Human), 小鼠(Mouse), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: CL2A-SN-38
CAS号: 1469876-18-3 Compound CID : 91668184SMILES: See more
-
Ozoralizumab (anti-TNF-alpha&HSA)
- 简短描述: Purity≥90% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human)
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 1167985-17-2 -
Sacituzumab govitecan (anti-TROP2)关联靶标: TACSTD2
- 简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Human IgG1; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Conjugated (Mc-VC-PAB-SN38)
- 种属反应性: 人(Human), 食蟹猴(Cynomolgus monkey)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: Mc-VC-PAB-SN38
CAS号: 1491917-83-9SMILES: [Sacituzumab govitecan] -
Blinatumomab (anti-CD3&CD19)
- 简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; CHO; ELISA, Flow Cytometry; Unconjugated
- 种属反应性: 人(Human)
- 宿主种属: 人(Human)
- 偶联: Unconjugated
CAS号: 853426-35-4 -
Brentuximab vedotin (anti-CD30)关联靶标: TNFRSF8
- 简短描述: Purity>90% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Conjugated (MC-VC-PAB-MMAE)
- 种属反应性: 人(Human)
- 亚型: Human IgG1
- 宿主种属: 人(Human)
- 偶联: MC-VC-PAB-MMAE
CAS号: 914088-09-8SMILES: [Brentuximab vedotin] -
Catumaxomab (anti-CD3&EpCAM)
- 简短描述: Purity≥90% (SDS-PAGE&SEC-HPLC); Endotoxin Level<1.0 EU/mg; Mouse IgG2a & Rat IgG2b; CHO; ELISA, Flow Cytometry, Functional assay, Animal Model; Unconjugated
- 种属反应性: 人(Human), 大鼠(Rat), 小鼠(Mouse)
- 亚型: Mouse IgG2a & Rat IgG2b
- 宿主种属: 小鼠(Mouse), 大鼠(Rat)
- 偶联: Unconjugated
CAS号: 509077-98-9
